Viral Vectors for Cancer Immunotherapy

Frontiers in Bioscience - Landmark - United States
doi 10.2741/1838
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers in Bioscience

Related search

Artificially Cloaked Viral Nanovaccine for Cancer Immunotherapy

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2019English

Non‐viral Gene Delivery for Cancer Immunotherapy

Journal of Gene Medicine
Molecular MedicineDrug DiscoveryGeneticsMolecular Biology
2019English

Viral Vectors Selective for Metastatic Breast Cancer Tumor Cells

1999English

Reprogramming Immune Response With Capsid-Optimized AAV6 Vectors for Immunotherapy of Cancer

Journal of immunotherapy (Hagerstown, Md. : 1997)
Cancer ResearchAllergyImmunologyPharmacology
2015English

Viral Vectors for Vaccine Development

2013English

Immunotherapy for Viral and Fungal Infections

Bone Marrow Transplantation
TransplantationHematology
2015English

221. The Utilization of Capsid-Optimized Adeno-Associated Virus (AAV) Vectors for Cancer Immunotherapy

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2015English

Plasmoviruses: Nonviral/Viral Vectors for Gene Therapy.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1996English

Vaccine Trials for the Clinician: Prospects for Viral and Non‐Viral Vectors

Oncologist
Cancer ResearchMedicineOncology
1997English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy